198 related articles for article (PubMed ID: 31761974)
1. Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Matsuda Y; Tahara K; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Nakura M; Morita T; Yamaguchi T; Koyama A
Support Care Cancer; 2020 Jun; 28(6):2931-2939. PubMed ID: 31761974
[TBL] [Abstract][Full Text] [Related]
2. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
[TBL] [Abstract][Full Text] [Related]
3. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC
BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817
[TBL] [Abstract][Full Text] [Related]
4. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
Zhang M; Li H; Ji Z; Dong D; Yan S
Medicine (Baltimore); 2017 Mar; 96(10):e6243. PubMed ID: 28272220
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
8. Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.
Matsuoka H; Tagami K; Ariyoshi K; Oyamada S; Kizawa Y; Inoue A; Koyama A
Jpn J Clin Oncol; 2019 May; 49(5):486-490. PubMed ID: 30793161
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Persistent Somatoform Pain Disorder by Floating Needle Therapy and Duloxetine].
Ren WW; Zhou ZY; Xu MM; Long S; Tang GZ; Mao HJ; Chen SL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Feb; 36(2):166-71. PubMed ID: 27078991
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
11. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.
Dworkin RH; Turk DC; Trudeau JJ; Benson C; Biondi DM; Katz NP; Kim M
J Pain; 2015 Apr; 16(4):357-66. PubMed ID: 25640290
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Duloxetine in Patients with Central Post-stroke Pain: A Randomized Double Blind Placebo Controlled Trial.
Mahesh B; Singh VK; Pathak A; Kumar A; Mishra VN; Joshi D; Chaurasia RN
Pain Med; 2023 Jun; 24(6):610-617. PubMed ID: 36409018
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial.
Vranken JH; Hollmann MW; van der Vegt MH; Kruis MR; Heesen M; Vos K; Pijl AJ; Dijkgraaf MGW
Pain; 2011 Feb; 152(2):267-273. PubMed ID: 21078545
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component: A Randomized, Double-blind, Placebo-controlled Crossover Trial.
Schukro RP; Oehmke MJ; Geroldinger A; Heinze G; Kress HG; Pramhas S
Anesthesiology; 2016 Jan; 124(1):150-8. PubMed ID: 26517858
[TBL] [Abstract][Full Text] [Related]
20. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Konno SI; Alev L; Oda N; Ochiai T; Enomoto H
Pain Med; 2019 Aug; 20(8):1479-1488. PubMed ID: 30856270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
